However, improved tumor growth control in a model of murine pancreatic adenocarcinoma was observed only in the DGKζ knockout mice and not in Cbl-b knockout mice indicating that DGKζ might be a better therapeutic target. The gene discussed is CBLB; the disease is neoplasm.